首页> 外国专利> Therapeutic agents for use in the treatment of tumors, acquired immune deficiency syndrome and leukemia by dual immune biostimulation

Therapeutic agents for use in the treatment of tumors, acquired immune deficiency syndrome and leukemia by dual immune biostimulation

机译:通过双重免疫生物刺激治疗肿瘤,获得性免疫缺陷综合症和白血病的治疗剂

摘要

The present invention relates to compositions for use in humans and animals as therapeutic agents for the treatment of tumors, acquired immune deficiency syndrome and leukemia. The composition of the present invention for use in humans and animals as an anticancer agent is a Lactobacillus reuteri capable of strongly stimulating the production of inflammatory cytokine (Th1) interferon (INF) -γ that exhibits significant antitumor activity. LRE03 strain DSM 23879 and / or a mixture comprising or preferably consisting of Lactobacillus salivarius LS06 strain DSM 26037 capable of strongly stimulating the production of dendritic cells exhibiting significant antitumor activity.
机译:本发明涉及在人和动物中用作治疗肿瘤,获得性免疫缺陷综合症和白血病的治疗剂的组合物。用于人和动物的本发明的组合物作为抗癌剂是能够强烈刺激表现出显着的抗肿瘤活性的炎性细胞因子(Th1)干扰素(INF)-γ的产生的路氏乳杆菌。 LRE03菌株DSM 23879和/或包含唾液乳杆菌LS06菌株DSM 26037或优选由其组成的混合物,其能够强烈刺激具有显着抗肿瘤活性的树突状细胞的产生。

著录项

  • 公开/公告号JP2017514857A

    专利类型

  • 公开/公告日2017-06-08

    原文格式PDF

  • 申请/专利权人 ジョヴァンニ・モーニャ;

    申请/专利号JP20160566657

  • 发明设计人 ジョヴァンニ・モーニャ;

    申请日2015-04-30

  • 分类号A61K35/747;A61K35/74;A61K36/886;A61P35;A61P35/02;A61P31/18;A61K47/26;A61K47/36;A61K47/46;

  • 国家 JP

  • 入库时间 2022-08-21 13:57:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号